Literature DB >> 24610176

Antineutrophil cytoplasmic antibody-associated vasculitis associated with Epstein-Barr virus infection: a case report and review of the literature.

P Xu1, S Lin, L Wei, W Shang.   

Abstract

A 16-year-old female with fever was admitted to our hospital. On admission, her serum IgM antibody against Epstein-Barr virus (EBV) was positive. Then, the disease aggravated and acute kidney injury occurred gradually. Antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) was confirmed by serum test and kidney biopsy. The patient was treated with oral methylprednisolone. Along with the disappearance of the IgM anti-EBV antibody, the AAV also relieved without relapse during follow-up for half a year. Although a previous study indicated that there was a high positive rate of ANCA in the sera positive for IgM antibodies to EBV and EBV infection might trigger the relapse of AAV, this is the first case of incipient AAV associated with acute EBV infection. One possible explanation might be that EBV infection stimulated the production of ANCA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24610176     DOI: 10.1007/s15010-014-0606-4

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   7.455


  20 in total

1.  Autoimmunity in multiple sclerosis: study of a wide spectrum of autoantibodies.

Authors:  M Spadaro; M A Amendolea; M G Mazzucconi; R Fantozzi; R Di Lello; P Zangari; G Masala
Journal:  Mult Scler       Date:  1999-04       Impact factor: 6.312

2.  Fever and increasing cANCA titre after kidney and autologous stem cell transplantation for Wegener's granulomatosis.

Authors:  T Daikeler; C Erley; M Mohren; C Amberger; H Einsele; L Kanz; I Kötter
Journal:  Ann Rheum Dis       Date:  2005-04       Impact factor: 19.103

3.  Fatal relapse of ANCA-associated glomerulonephritis triggered by successive Epstein-Barr and varicella zoster virus infections.

Authors:  Alan R Schned; Kim Ornvold; Gregory J Tsongalis; Michael C Chobanian
Journal:  Am J Kidney Dis       Date:  2006-05       Impact factor: 8.860

4.  Antineutrophil cytoplasmic antibody in patients with primary Sjögren's syndrome.

Authors:  K Nishiya; H Chikazawa; K Hashimoto; S Miyawaki
Journal:  Clin Rheumatol       Date:  1999       Impact factor: 2.980

Review 5.  Type I interferons (alpha/beta) in immunity and autoimmunity.

Authors:  Argyrios N Theofilopoulos; Roberto Baccala; Bruce Beutler; Dwight H Kono
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

Review 6.  Interferon-alpha and -beta in kidney inflammation.

Authors:  Hans-Joachim Anders; Julia Lichtnekert; Ramanjaneyulu Allam
Journal:  Kidney Int       Date:  2010-03-17       Impact factor: 10.612

7.  Comparison of characteristics of natural autoantibodies against myeloperoxidase and anti-myeloperoxidase autoantibodies from patients with microscopic polyangiitis.

Authors:  Peng-Cheng Xu; Zhao Cui; Min Chen; Thomas Hellmark; Ming-Hui Zhao
Journal:  Rheumatology (Oxford)       Date:  2011-03-03       Impact factor: 7.580

8.  Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease.

Authors:  George E Reese; Vasilis A Constantinides; Constantinos Simillis; Ara W Darzi; Timothy R Orchard; Victor W Fazio; Paris P Tekkis
Journal:  Am J Gastroenterol       Date:  2006-09-04       Impact factor: 10.864

9.  Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis.

Authors:  Amelia Ruffatti; Renato Alberto Sinico; Antonella Radice; Elena Ossi; Franco Cozzi; Marta Tonello; Panagiotis Grypiotis; Silvano Todesco
Journal:  J Rheumatol       Date:  2002-05       Impact factor: 4.666

10.  What is behind the presence of anti-neutrophil cytoplasmatic antibodies in chronic liver disease?

Authors:  Valentina De Riva; Marilena Celadin; Marina Pittoni; Mario Plebani; Paolo Angeli
Journal:  Liver Int       Date:  2009-05-06       Impact factor: 5.828

View more
  6 in total

1.  Fatal Systemic Vasculitis Associated with Chronic Active Epstein-Barr Virus Infection.

Authors:  Oumama Jamal; Nawal Sahel; Rachida Saouab; Mohammed El Qatni; Meryem Zaizaa; Ilyas El Kassimi; Adil Rkiouak; Salaheddine Hammi; Youssef Sekkach
Journal:  Mo Med       Date:  2021 May-Jun

2.  Epstein-Barr virus infection associated polymyositis and coronary artery dilation.

Authors:  Liping Teng; Chencong Shen; Weizhong Gu; Jianqiang Wu; Meiping Lu; Xuefeng Xu
Journal:  BMC Infect Dis       Date:  2022-03-07       Impact factor: 3.090

Review 3.  Environmental factors influencing the risk of ANCA-associated vasculitis.

Authors:  Wen-Man Zhao; Zhi-Juan Wang; Rui Shi; Yu-Yu Zhu; Sen Zhang; Rui-Feng Wang; De-Guang Wang
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

Review 4.  Virus-Associated Nephropathies: A Narrative Review.

Authors:  Christophe Masset; Paul Le Turnier; Céline Bressollette-Bodin; Karine Renaudin; François Raffi; Jacques Dantal
Journal:  Int J Mol Sci       Date:  2022-10-10       Impact factor: 6.208

Review 5.  Pathophysiological Relationship between Infections and Systemic Vasculitis.

Authors:  Carolina Muñoz-Grajales; Juan C Pineda
Journal:  Autoimmune Dis       Date:  2015-07-07

6.  Acute Acalculous Cholecystitis Associated with Epstein-Barr Infection: A Case Report and Review of the Literature.

Authors:  Konstantinos Ntelis; Dimosthenis Mazarakis; Apostolos Sapountzis; Dimitra Zissi; Sophia Sparangi; Nikoletta Xidia; Dimitrios Velissaris
Journal:  Case Rep Med       Date:  2020-01-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.